History | Avapritinib for treating advanced systemic mastocytosis | Guidance | NICE

History

Documents created during the development process.

Final draft guidance

Final draft guidance
Committee papers (PDF 10.15 MB)

Published:

03 October 2024
Public committee slides (PDF 873 KB)

Published:

03 October 2024
Equality and health inequalities assessment (downloadable version) (PDF 144 KB)

Published:

03 October 2024
Final draft guidance (PDF 180 KB)

Published:

03 October 2024

Declaration of interests

Register of interests (PDF 151 KB)

Published:

11 November 2024

Invitation to participate

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 521 KB)

Published:

20 November 2023
Final scope (PDF 180 KB)

Published:

20 November 2023
Final stakeholder list (PDF 169 KB)

Published:

20 November 2023
Equality Impact Assessment (Guidance development) (PDF 125 KB)

Published:

20 November 2023

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 3770

Draft scope post referral (PDF 194 KB)

Published:

18 July 2023
Draft matrix post referral (PDF 170 KB)

Published:

18 July 2023